Pathophysiology of Type 2 Diabetes Mellitus
Type 2 Diabetes Mellitus (T2DM), one of the most common metabolic disorders, is caused by a combination of two primary factors: defective insulin secretion by pancreatic β-cells and the inability of insulin-sensitive tissues to respond appropriately to insulin. Because insulin release and activity are essential processes for glucose homeostasis, the molecular mechanisms involved in the synthesis and release of insulin, as well as in its detection are tightly regulated. Defects in any of the mechanisms involved in these processes can lead to a metabolic imbalance responsible for the development of the disease. This review analyzes the key aspects of T2DM, as well as the molecular mechanisms and pathways implicated in insulin metabolism leading to T2DM and insulin resistance. For that purpose, we summarize the data gathered up until now, focusing especially on insulin synthesis, insulin release, insulin sensing and on the downstream effects on individual insulin-sensitive organs. The review also covers the pathological conditions perpetuating T2DM such as nutritional factors, physical activity, gut dysbiosis and metabolic memory. Additionally, because T2DM is associated with accelerated atherosclerosis development, we review here some of the molecular mechanisms that link T2DM and insulin resistance (IR) as well as cardiovascular risk as one of the most important complications in T2DM.
Top-30
Journals
|
10
20
30
40
50
60
70
80
|
|
|
International Journal of Molecular Sciences
72 publications, 3.53%
|
|
|
Cureus
56 publications, 2.74%
|
|
|
Nutrients
50 publications, 2.45%
|
|
|
Frontiers in Endocrinology
49 publications, 2.4%
|
|
|
Molecules
27 publications, 1.32%
|
|
|
Frontiers in Pharmacology
25 publications, 1.22%
|
|
|
Scientific Reports
24 publications, 1.18%
|
|
|
Biomedicines
21 publications, 1.03%
|
|
|
PLoS ONE
20 publications, 0.98%
|
|
|
Journal of Diabetes and Metabolic Disorders
17 publications, 0.83%
|
|
|
Heliyon
17 publications, 0.83%
|
|
|
Pharmaceuticals
16 publications, 0.78%
|
|
|
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
16 publications, 0.78%
|
|
|
Frontiers in Nutrition
15 publications, 0.73%
|
|
|
Life
14 publications, 0.69%
|
|
|
Biomedicine and Pharmacotherapy
14 publications, 0.69%
|
|
|
World Journal of Diabetes
13 publications, 0.64%
|
|
|
Cells
12 publications, 0.59%
|
|
|
Current Diabetes Reviews
12 publications, 0.59%
|
|
|
Current Issues in Molecular Biology
11 publications, 0.54%
|
|
|
Journal of Clinical Medicine
11 publications, 0.54%
|
|
|
Journal of Ethnopharmacology
11 publications, 0.54%
|
|
|
International Journal of Biological Macromolecules
11 publications, 0.54%
|
|
|
Food Bioscience
11 publications, 0.54%
|
|
|
Diagnostics
11 publications, 0.54%
|
|
|
Metabolites
10 publications, 0.49%
|
|
|
Medicine (United States)
10 publications, 0.49%
|
|
|
Foods
10 publications, 0.49%
|
|
|
Antioxidants
10 publications, 0.49%
|
|
|
10
20
30
40
50
60
70
80
|
Publishers
|
50
100
150
200
250
300
350
400
450
500
|
|
|
Elsevier
486 publications, 23.8%
|
|
|
MDPI
386 publications, 18.9%
|
|
|
Springer Nature
369 publications, 18.07%
|
|
|
Wiley
135 publications, 6.61%
|
|
|
Frontiers Media S.A.
125 publications, 6.12%
|
|
|
Taylor & Francis
86 publications, 4.21%
|
|
|
Bentham Science Publishers Ltd.
43 publications, 2.11%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
26 publications, 1.27%
|
|
|
Cold Spring Harbor Laboratory
26 publications, 1.27%
|
|
|
Public Library of Science (PLoS)
21 publications, 1.03%
|
|
|
SAGE
20 publications, 0.98%
|
|
|
American Chemical Society (ACS)
17 publications, 0.83%
|
|
|
Baishideng Publishing Group
17 publications, 0.83%
|
|
|
Oxford University Press
15 publications, 0.73%
|
|
|
Royal Society of Chemistry (RSC)
15 publications, 0.73%
|
|
|
IntechOpen
15 publications, 0.73%
|
|
|
Hindawi Limited
13 publications, 0.64%
|
|
|
Walter de Gruyter
11 publications, 0.54%
|
|
|
Institute of Electrical and Electronics Engineers (IEEE)
11 publications, 0.54%
|
|
|
Spandidos Publications
8 publications, 0.39%
|
|
|
Research Square Platform LLC
8 publications, 0.39%
|
|
|
The Endocrine Society
7 publications, 0.34%
|
|
|
JMIR Publications
7 publications, 0.34%
|
|
|
BMJ
7 publications, 0.34%
|
|
|
Georg Thieme Verlag KG
6 publications, 0.29%
|
|
|
Medknow
6 publications, 0.29%
|
|
|
Mary Ann Liebert
5 publications, 0.24%
|
|
|
King Saud University
5 publications, 0.24%
|
|
|
American Diabetes Association
5 publications, 0.24%
|
|
|
50
100
150
200
250
300
350
400
450
500
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.